Skip to main content
. 2017 Sep 7;2017:8232863. doi: 10.1155/2017/8232863

Table 2.

Observed means of outcome measures over time.

Valid N Baseline Three months Six months Overall p
Mood outcomes
Depression—CES-D 50 26.84 (24.52–29.16)A 15.03 (12.69–17.37)B 12.12 (9.73–14.52)B <0.001
Depression—PHQ-9 50 11.50 (10.16–12.84)A 5.94 (4.59–7.28)B 5.21 (3.83–6.59)B <0.001
State anxiety 50 42.42 (39.39–45.45)A 35.94 (32.88–39.00)B 32.93 (29.80–36.06)B <0.001
Trait anxiety 50 49.24 (46.69–51.79)A 40.49 (37.93–43.05)B 36.36 (33.75–38.97)C <0.001
Health status
Mental SF-12 50 35.30 (32.61–37.99)A 46.27 (43.56–48.98)B 49.15 (46.36–51.93)B <0.001
Physical SF-12 50 45.56 (42.49–48.63)A 44.94 (41.86–48.03)A 44.31 (41.19–47.42)A 0.51
Laboratory measures
25-Hydroxyvitamin D (ng/ml)
Total 25 (OH) D 50 19.18 (16.77–21.59)A 34.29 (31.87–36.72)B 37.60 (35.12–40.08)C <0.001
25 (OH) D2 50 2.72 (0–7.69)A 31.29 (28.43–34.16)B 36.97 (34.03–39.92)C <0.001
25 (OH) D3 50 18.75 (17.33–20.16)A 7.33 (5.92–8.75)B 6.07 (4.61–7.53)B <0.001
25 (OH) D2 D3 50 20.37 (17.67–23.07)A 38.02 (35.32–40.72)B 43.08 (40.31–45.86)C <0.001
Serum calcium (mg/dl) 50 9.31 (9.20–9.43)A 9.30 (9.19–9.42)A 9.44 (9.32–9.56)A 0.043
Serum PTH (pg/ml) 50 48.38 (42.63–54.13)A 47.66 (41.89–53.43)A 44.94 (39.11–50.76)A 0.16
HbA1c (%) 50 6.87 (6.58–7.15)A 7.02 (6.74–7.31)AB 7.14 (6.85–7.43)B 0.01

Note: means are displayed with their 95% confidence interval in parentheses. Post hoc tests were conducted using the Sidak correction to control the type I error rate. Within each row, if two estimates are significantly different (p < 0.05), those values display different superscript letters.